Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Prudential Financial Inc (PRU) vs Revvity Inc (RVTY) Price & Performance

Prudential Financial IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Prudential Financial Inc vs Revvity Inc — how do they compare? Prudential Financial Inc trades at $112.98 (market cap $39.17B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Prudential Financial Inc is far larger — about 2.3× Revvity Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.93%). Which is the better fit depends on your goals — on Pluang, investors hold Prudential Financial Inc for 145 Days and Revvity Inc for 12 Days on average.

PRURVTY
Market Cap
$39.17B$16.98B
Volume
1,436,9171,456,900
Sector
FinancialsHealth
52-Week High
$125.13$157.36
52-Week Low
$92.00$82.26
Typical Hold Time
145 Days12 Days
Enterprise Value
$67.95B$19.30B
Dividend Yield
4.93%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Prudential Financial Inc

Prudential Financial (PRU) trades at $112.97, up 0.54% with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent strategic moves include the Alexforbes stake sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.

While PRU offers value appeal through strong fundamentals and dividend yield, investors face headwinds from bearish technicals and mixed analyst sentiment. The company's capital rotation strategy and PGIM growth initiatives provide upside potential, but execution risks and market volatility remain concerns. Current price sits above consensus target of $105.67, suggesting limited near-term upside.

Revvity Inc

RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.

The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PRU
9% Buy91% Sell
Avg holding period · 145 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Prudential Financial Inc

Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.

Read more on PRU →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →